Clinical Study of BCT301 Cell Injection Therapy for Refractory Autoimmune Diseases

NCT07301164 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

NOT_YET_RECRUITING

Status

10

Enrollment

OTHER

Sponsor class

Conditions

System Lupus Erythematosus
Systemic Sclerosis (SSc)
Inflammatory Myositis
Antiphospholipid Syndrome
ANCA Associated Vasculitis
Sjogren Syndrome

Interventions

BIOLOGICAL: BCT301

Sponsor

Peking University Third Hospital